|
Volumn 309, Issue 12, 2013, Pages 1235-1236
|
The economics of genomic medicine: Insights from the IOM roundtable on translating genomic-based research for health
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CLINICAL RESEARCH;
CULTURAL FACTOR;
ECONOMIC ASPECT;
EXOME;
FUNCTIONAL GENOMICS;
GENE SEQUENCE;
GENETIC SCREENING;
GENOTYPE;
HEALTH CARE DELIVERY;
HEALTH CARE PRACTICE;
HEALTH CARE SYSTEM;
HEALTH ECONOMICS;
HUMAN;
HUMAN GENOME;
PRIORITY JOURNAL;
RISK ASSESSMENT;
SHORT SURVEY;
TRANSLATIONAL RESEARCH;
ARTICLE;
DNA SEQUENCE;
ECONOMICS;
GENOMICS;
METHODOLOGY;
ORGANIZATION;
OUTCOME ASSESSMENT;
UNITED STATES;
DELIVERY OF HEALTH CARE;
GENETIC TESTING;
GENOMICS;
HUMANS;
INSTITUTE OF MEDICINE (U.S.);
OUTCOME ASSESSMENT (HEALTH CARE);
SEQUENCE ANALYSIS, DNA;
TRANSLATIONAL MEDICAL RESEARCH;
UNITED STATES;
MLCS;
MLOWN;
|
EID: 84875488700
PISSN: 00987484
EISSN: 15383598
Source Type: Journal
DOI: 10.1001/jama.2013.113 Document Type: Short Survey |
Times cited : (30)
|
References (7)
|